VEGFA and Miyoshi myopathy: Several reports affirming the clinical impact of hepatocyte growth factor, vascular endothelial growth factor, and antiapoptotic signaling pathways validate that growth factors are indeed crucial in maintaining the tumor progression in MM [83,84,85].